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ABSTRACT 
Objectives; Salmonella enteritica infections can lead to Reactive Arthritis (ReA), which can exhibit 
an association with Human Leucocyte Antigen (HLA)-B*27:05, a molecule prone to misfolding and 
initiation of the Unfolded Protein Response (UPR). This study examined how HLA-B*27:05 
expression and the UPR affects the Salmonella life cycle within epithelial cells.  
Methods; Isogenic epithelial cell lines expressing two copies of either HLA-B*27:05 and a control 
HLA-B*35:01 heavy chain (HC)  were generated to determine the effect on the Salmonella infection 
lifecycle. A cell line expressing HLA-B*27:05.HC physically linked to the light chain beta-2-
microglobulin and a specific peptide (referred to as a single chain trimer, SCT) was also generated 
to determine the effects of HLA-B27 folding status on S.enteritica life cycle. XBP-1venus and ATF6-
FLAG reporters were used to monitor UPR activation in infected cells. Triacin C was used to inhibit 
de novo lipid synthesis during UPR and confocal imaging of ER tracker stained membrane allowed 
quantification of glibenclamide associated membrane. 
Results; S.enteritica demonstrated enhanced replication with an altered cellular localisation in the 
presence of HLA-B*27:05.HC but not in the prescence of HLA-B*27:05.SCT or HLA-B*35:01. HLA-
B*27:05.HC altered the threshold for UPR induction. Salmonella activated the UPR and required 
XBP-1 for replication, which was associated with endoreticular-membrane expansion and lipid 
metabolism.  
Conclusions; HLA-B27 misfolding and an UPR cellular environment is associated with enhanced 
Salmonella replication, whilst Salmonella itself can activate XBP-1 and ATF6. These data provide a 
potential mechanism linking the life cycle of Salmonella with the physicochemical properties of HLA-
B27 and cellular events that may contribute to ReA pathogenesis. 
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INTRODUCTION 
 
Misfolding of the Human Leucocyte Antigen B27 allele (HLA-B27) is known to induce the unfolded 
protein response (UPR),1 2 has been proposed to explain why HLA-B27 drives the inflammatory 
arthritic disorder Ankylosing Spondylitis (AS). Protein misfolding within the ER can disrupt ER 
homeostasis and trigger the UPR as measured by activation of the XBP-12 and ATF6 pathways1 
and in AS patients, by upregulating the UPR effector gene, HRD1. 3  
 
The clinical manifestation of Reactive Arthritis (ReA) after Salmonella enterica (S. enteritica) 
infection, has a mixed association with HLA-B27.4. Some studies suggest that HLA-B27-positive 
individuals exhibit increased susceptibility to ReA5 6 7or increased risk to Salmonella infection 8 whist 
others have found no strong association. 9 10 11 S. enteritica grows within a specialized membrane-
bound compartment termed the Salmonella containing vacuole (SCV), prior to cellular escape and 
dissemination.12-14 The mechanistic link between intracellular bacteria and HLA-B27 is unknown, but 
mammalian cell lines expressing HLA-B27 can harbour higher numbers of internal Salmonella.15-17 
 
We have previously shown that fusing the HLA-B27 HC, beta-2-microglobulin (2m) and presented 
peptide together within a single chain trimer (SCT) significantly reduces misfolding relative to the 
orginal HC.18 Here we have used the SCT to test the hypothesis that HLA-B27 misfolding impacts 
on endocellular growth and localisation of S. enteritica in infected cells. We also tested the extent to 
which S. enteritica influences activation of both the XBP1 and ATF6-mediated UPR pathway.  
 
MATERIALS AND METHODS 
Unfolded Protein Response induction 
UPR responses were induced with tunicamycin (TUN), thapsigargin (TPG), MG-132, or Calcimycin 
(A23187) from Calbiochem, with appropriate vehicle (DMSO alone) controls. 
 
Transfection of UPR reporter constructs 
Polyethylenimine (PEI, JetPrime) was used to transfect cells with the UPR reporter plasmids 
DBDXBP-1venus(v) and ATF6-FLAG 19 20 following manufacturer’s conditions. Cells were fixed at 
the desired  post-infection (p.i) time points for 10 mins with 3.8% paraformaldehyde (PFA: pH 7.4) 
and fluorescence measured using LSR2 and LSR Fortessa flow cytometers (BD Biosciences), and 
data analyzed using FlowJo 8.7.3 software. 
 
S. enteritica colony forming unit enumeration and microscopy 
Colony forming unit (cfu) enumeration was performed by lysing cells in 1% Triton X-100/PBS. 
Lysates were serially diluted into 1% bovine serum albumin (BSA)/0.1% Tween-80%   and plated on 
LB agar at room temperature for ~16hrs. Each experimental condition was performed in triplicate 
and each plating in duplicate. For microscopic analysis, coverslips containing infected cells were 
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washed with 1x DPBS, fixed for 10 mins with 3.8% PFA (pH 7.4), washed twice with 1x DPBS and  
stored at 4ºC. 
  
UPR-mediated membrane expansion during infection 
Glibenclamide BODIPY-FL (green, Invitrogen) was used to quantitate endo-reticular membrane size 
and localization. HeLa cells were treated with UPR inducing drugs and labelled with Glibenclamide 
according to manufacturers protocol. Labelled cells were analyzed by FACS. Cell nuclei were 
counterstained with DAPI and visualised by fluorescence microscopy. For control and drug treated 
cells equivalent exposures were collected. 
 
To determine endoreticular derived membrane expansion during infection, HeLa cells were grown 
either on sterile glass, infected with S. enterica Typhimurium expressing mCherry (see 
supplementary materials and methods) and stained with Glibenclamide Green. Cells were fixed, 
washed and counterstained with DAPI followed by fluorescence microscopy or automated confocal 
analysis. Images were acquired by an Opera LX (PerkinElmer) plate reader with a confocal 
microscope (NA=0.6, 40x air objective). Exposure times were; 100ms for the DAPI channel (365 
nm), 2000 ms for the ER channel (488 nm), 2000 ms for the Salmonella channel (561 nm). Camera 
pixels were binned by 2 resulting in a pixel size of 0.323 x 0.323µm. 4800 images were acquired per 
96-well plate (50 images per well) that was processed in one batch using the same image analysis 
pipeline, algorithms and parameters. See supplementary materials and methods for analysis of 
Glibenclamide mean fluorescence intensity (MFI).  
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RESULTS 
 
XBP-1 and ATF6 activation following Salmonella infection. We utlised our previously described 
epithelial cells with identical sites of transgene integration (and therefore isogenic) expressing 
physiological levels of HLA-B273(Figure S1A-E). Control cell lines encoding HLA-B*35:01 HC (HLA-
B35.HC) transgene or the FRT vector alone (referred as Empty (E)84) were generated  (integration 
at the same two loci). HLA-B27 and –B35.HC lines were incubated with or without the influenza 
nucleoprotein peptide 383-391 (NP383-391). The ability of HLA-B27 to present cognate peptide to 
NP383-391-specific CD8+ cytotoxic T lymphocytes (CTL) was confirmed by an increase in CD107a cell 
surface expression (Figure S1F, top right panel). Two dimensional immunoblotting of cell lysates 
revealed HLA-B27.HC can form HC-dimers under these experimental conditions (Figure 1A, arrow 
top panel) but only monomeric HLA-B35.HC was detected (Figure 1A, bottom panel).  
 
HLA-B27 expression can activate XBP-1,2 21 therefore we determined whether our cell lines had 
altered sensitivity to UPR induction. Using the XBP-1vDBD reporter, which on splicing the 26bp 
intronic sequences leads to GFP expression19 we observed no induction of the UPR within these 
cell lines under normal culture growth conditions. Reasoning the expression of HLA-B27 could alter 
the threshold at which the UPR could be activated, we monitored XBP-1vDBD activation with 
increasing concentrations of the UPR inducing agent thapsigagrin (TPG). HLA-B27 positive cells 
had an altered threshold for UPR induction, whilst the E84 and B35 lines did not exhibit significant 
differences (Figure 1B).  
 
Next, we determined whether Salmonella affected the UPR in the absence of HLA-B27 expression. 
Cells were infected with S.enterica expressing mCherry (referred to as ST.mCherry) and activation 
of DBDXBP-1v was monitored following various multiplicity of infections (MOI)  including 3:1, 50:1 
and 100:1 over 1, 4, 8 and 24hrs. XBP-1s activation was determined by the fold increase in MFI 
above the uninfected DBDXBP-1v transfected cells. Infection led to enhanced XBP-1s protein 
levels  8-24hrs post infection (p.i.) (Figure 1C). TLR ligands LPS and flagellin did not activate the 
DBDXBP-1v reporter and heat killed bacteria had minimal impact (Figure 1D). Endogenous XBP-
1s mRNA levels were then quantified and QPCR of XBP-1s transcript levels showed increased 
expression 8–16hrs p.i. demonstrating activation of the IRE-1 pathway (Figure 1E). We also 
examined the impact of infection on the ATF6 pathway. Cells were transfected with ATF6.FLAG and 
the cleaved cytosolic-FLAG tagged domain was quantified by immunoblotting p.i. Peak cleavage of 
the ATF6 cytosolic domain was observed 12hrs p.i. (Figure 1F-G) with a 1.5-2.5 fold increase in 
activation in infected compared to non-infected cells. HeLa.B27.HC and -B35.HC expressing cell 
lines were then tested for their ability to support bacterial growth. Cells were infected with S.enterica 
for 24hrs prior to enumeration of cfu. A 4-5 fold increase in cfu from HLA-B27.HC expressing cells 
was observed compared to cells expressing HLA-B35.HC or E84 controls (data not shown) (Figure 
1H).  
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XBP-1 pathway is required for efficient Salmonella enterica Typhimurium replication. Our 
observations suggested that activation of the XBP-1 pathway plays a significant role in S. enterica 
growth and replication. To support our hypothesis, we analysed S. enterica replication in XBP-1 
deficient mouse embryonic fibroblasts (MEF). XBP-1+/+ and XBP-1-/- MEF cell lines were infected 
with ST.mCherry, harvested and analyzed by flow cytometry. Importantly the MFI, which is a 
measure of the average number of bacteria per cell, for both cell types were similar at 1 and 4hrs 
p.i., indicating no significant differences in either bacterial invasion or early infection stages. 
However, when the bacteria began replication, the XBP-1-/- MEF cell line exhibited significantly 
lower MFI values than the XBP-1+/+ cell line indicating reduced bacterial growth (Figures 2A). XBP-
1+/+ cells had approximately three fold more bacteria than in XBP-1-/- cells during the replication 
phase (8-24hrs p.i.) (Figures 2B-C).  
 
Enhanced bacterial replication is linked to UPR induced lipid metabolism. Next we wished to 
test the hypothesis that UPR promotes Salmonella replication. To mimic UPR conditions, HeLa cells 
were pretreated with the following UPR inducing pharmacological agents; A23187 (0.5mM), MG132 
(0.5g/mL), tunicamycin (TUN), (0.5g/mL) and TPG (200nM) (see Figure 3A for mode of action). 
HeLa cells were treated with DMSO (vehicle control) or the respective UPR inducer 16hrs prior to 
infection with ST.mCherry and the fold increase in infected cells over the control was determined 
24hrs p.i. Overall the data indicate that an UPR environment leads to an increase in intracellular 
Salmonella (Figure 3B).  
 
TPG appeared to have a more pronounced effect on Salmonella replication and also has the most 
direct effect on ER homeostasis (Figure 3A). We employed TPG further to determine the effect of a 
pre-existing ER stress environment. HeLa cells were treated with TPG at 25, 100 and 400nM 16hrs 
prior to infection. TPG pretreated cells showed significant increases in the MFI of infected cells 
when compared to the controls (Figure 3C). A 4-7 fold increase in TPG treated cells  was recorded 
24hrs p.i. (Figure 3D). Interestingly, flow cytometry revealed no significant difference in the 
percentage of HeLa cells infected with increasing TPG concentrations (Figure S2A). Direct 
quantification of bacterial replication by cfu recovery also demonstrated significant increase in 
bacterial numbers in TPG treated cells at 8 and 24hrs p.i. (Figure 3E). Depending on the signals 
and duration, UPR can lead to production of pro or anti-apoptotic factors. The observed increase in 
bacterial counts 8hrs p.i. maybe due to  the production of anti-apoptotic factors. To assess the level 
of cell death, activation of caspases was followed by staining with the FITC conjugated pan caspase 
detection reagent FLICA and the live dead dye 647. Treatment of cells with UPR inducing drugs  did 
not alter activation of caspases or induction of cell death during infection indicating that the 
observed enhanced bacterial counts post-UPR is not linked to increased cellular death (Figure S3).  
 
Salmonella replication and intracellular niche development require a source of membrane which 
would depend in part on lipid biosynthetic pathways, which can be activated and/or enhanced by  
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the UPR. We therefore inhibited de novo synthesis of long chain fatty acid synthesis during the 
induction of the UPR with Triacin C (TRC), a potent inhibitor of long fatty acyl CoA synthetase 
isoforms 1, 3 and 4. HeLa cells were treated with DMSO, TRC (200 nM), TPG (200 nM), or co-
treated with TRC (200nM) and TPG (200nM) 16hrs prior to infection. TRC treatment prior to 
infection did not significantly alter the percentage of cells infected either in the presence or absence 
of TPG (Figure S2B). Cells treated with TPG alone showed significant increases in MFI values of 
the infected cells when compared to the DMSO or TRC controls (Figure 4A). However, co-
treatment of cells with TRC and TPG significantly reduced the effect of the UPR induction on the 
levels of intracellular bacteria 24hrs p.i. (Figure 4A-B). These observations were confirmed by 
recovery of viable bacteria from similarly infected HeLa cells (Figure 4C) indicating inhibition of lipid 
metabolism during  UPR induction reduces the increase in intracellular bacteria observed at late 
time points.  
 
Salmonella infection leads to endoreticular-membrane expansion To determine whether the 
increase in intracellular bacteria from cells undergoing the UPR was dependent on replication within 
the SCV, we utilised the isogenic S. enterica Typhimurium sifA mutant which can infect but is 
impaired in intracellular growth and can escape the SCV.22-24 HeLa cells were treated with DMSO or 
200nM TPG 16hrs prior to infection with ST.mCherry or the isogenic sifA mutant. ST.mCherry 
exhibited significant increases after TPG treatment as already described. In marked contrast, UPR 
induced cells infected with the sifA mutant, demonstrated no increase in bacterial numbers (Figure 
5A). Thus, intracellular localization within the SCV is required for UPR mediated effects on bacterial 
replication.  
 
As UPR activation is associated with endoreticular membrane expansion and lipid metabolism,25 26 
we determined whether Salmonella infection could lead to expansion of endoreticular membrane 
during the replication/growth phase of its lifecycle using glibenclamide green ER tracker dye as a 
marker for endoreticular membranes. HeLa cells were infected with either wild-type or sifA 
ST.mCherry as a control strain. At 4 and 24hrs p.i., cells were stained with glibenclamide green ER 
tracker dye and analysed by automated confocal microscopy. The levels of glibenclamide labelled 
membrane in infected cells was quantified and compared to uninfected cells. An increase in 
glibenclamide labelling in cells infected with wild-type but not sifA deficient bacteria was observed 
(Figure 5B) which supports our observation that XBP-1 is not activated by sifA bacteria (data not 
shown).  
 
The folding status and expression of HLA-B27 alters Salmonella replication and cellular 
localisation. To address the role of the folding status of HLA-B27, we  generated an HLA-B27 
molecule fused to the light chain 2m and an HLA-B27 specific peptide derived from the influenza 
nucleoprotein (referred to as HLA-B27.Single Chain Trimer (HLA-B27.SCT)) As a control we also 
generated a similar fusion protein for HLA-B35 with EBNA1 peptide (Figure 6A). The HLA-B27 and 
–B35.SCTs were transfected into the original FLIPIN HeLa founder line. Functional activity of the 
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HLA-B27.SCT was determined by incubation ±NP383-391 peptide.  The HLA-B27.SCT line was an 
effective CTL target in the absence (Figure 6B, top left panel) and presence (Figure 6B, top right 
panel) of exogenously added peptide, whereas the HLA-B35.SCT line did not activate HLA-B27-NP 
restricted CTL lines (Figure 6B, bottom left and right panels). We next determined whether HLA-
B27.SCT could form dimeric conformations. Both cell lines were treated with NEM and lysates were 
seperated by charge and Mw as described previously. Immunoblotting with the anti-V5 tag antibody 
pK revealed that neither the HLA-B27 SCT or –B35 SCT lines form high Mw conformers (Figure 
6C, top and bottom panels respectively). 
 
Next, we wished to know whether HLA-B27.SCT cells could support enhanced Salmonella 
replication. HLA-B27.SCT, along with HLA-B35 and B27.HC lines were infected with ST.GFP. CFU 
recovery, determined 24hrs p.i. demonstrated enhanced numbers of bacteria in the B27.HC but not 
in the B27.SCT line (Figure 6D).  
 
As Salmonella survival can correlate with their intracellular localisation,27 we tracked ST.GFP within 
the different HLA-class I expressing cell lines using confocal microscopy. Following infection, cells 
were co-stained for the trans Golgi specific marker giantin (red) and the nucleus with DAPI (blue) 
(Figure 6E). In the E84 and HLA-B35.HC cell lines, we detected ST.GFP concentrated in 
juxtaposition to the Golgi apparatus, which reflects Salmonella within the SCV. Surprisingly, in the 
presence of HLA-B27.HC, we noted that Salmonella markedly do not reside in close proxiimity to 
the Golgi, but instead were located more within the periphery (Figure 6E, panel ii).  In contrast, in 
infected B27.SCT cells (Figure 6E, panel iv), the bacteria resided in similar locations to the B35 
and E84 cells (Figure 6E, panel iii), suggesting that bacterial location is associated with enhanced 
replication, in a process influenced by the folding efficiency of HLA-B27. 
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DISCUSSION 
Why Salmonella exhibits an association with ReA and HLA-B27 remains undetermined. Here we 
have analysed Salmonella growth where HLA-B27 misfolding and the UPR are limiting parameters. 
Our study demonstrates that it is not expression of HLA-B27 alone that results in enhanced bacterial 
replication, but HLA-B27 misfolding, which influences the ER stress environment. Our 
demonstration that HLA-B27 expression can reduce the threshold of ER stress induction and that 
Salmonella can induce the UPR provides key additional insight as to why such bacteria manipulate 
and exploit ER stress pathways to their benefit.  
 
In the presence of misfolding HLA-B27, Salmonella predominantly reside in an altered  peripheral 
cellular localisation. Thus HLA-B27 may alter SCV biogenesis and intracellular movement. 
Maturation of the SCV and bacterial cellular localisation can determine survival and replicative 
capability of Salmonella.14 22 27 28  During the early stages of infection, the SCV migrates by following 
an endosomal maturation route, to a juxtanuclear location associated with the microtubule 
organizing center (MTOC) and the Golgi apparatus in epithelial cells.13 14 It is possible that bacteria 
fail to form an SCV or exit the SCV more rapidly in the presence of misfolding HLA-B27 or escape 
from the SCV and randomly redistribute throughout the cytoplasm. Alternatively, Salmonella could 
initially occupy SCVs in juxtaposition to the Golgi and the movement to the periphery is enhanced in 
the prescence of HLA-B27.  
 
HLA-B27.HC expression and endocellular S. enteritica growth both independently cause activation 
of the XBP-1 ER-stress pathway. XBP-1 activation peaks at 8-16hrs p.i. (Figure 1D-E), which 
correlates with enhanced bacterial numbers in cells undergoing ER stress and/or expressing HLA-
B27.HC with a propensity to misfold. Activation of both XBP-1 and ATF6 coincides with the 
replication/growth phase of S.enterica Typhimurium. During this phase Salmonella membrane 
modifications have been reported to be at their peak29 which might therefore lead to UPR activation. 
We do not currently know the complete cellular stress response to Salmonella in our model cell 
system, but plan to address this by RNA-Seq to map other significant differences in how HLA-
B*27:05 and –B*35:01 expressing cells respond after infection. However, taken together, data 
reported here suggest the ER-stress consequences of HLA-B27 misfolding provide a favourable 
environment for replication of S. enteritica within HeLa cells. Interestingly, Salmonella infections can 
affect IL-23 production,30 a cytokine that has been implicated to be important in the disease 
phenotype of the spondyloarthropathies.31 It is possible that the co-occurrence of Salmonella and 
HLA-B27 could have a cumulative or multiplicative effect on the UPR which could explain the 
enhanced risk of ReA and/or an increased risk of symptomatic Salmonella infection in HLA-B27+ 
individuals in a population exposed to infection.5 6 8 However, the effects of HLA-B27 on Salmonella 
may depend on the temporal activation of the UPR.32 Our observations with pre-existing UPR 
activation do suggest that these aforementioned factors could indeed influence Salmonella 
replication. 
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The origin of the membrane that makes up the growing SCV remain poorly defined but ER 
membrane markers have been reported in SCVs. The ER membrane bound markers calnexin and 
PDI were demonstrated to co-distribute with SCVs and up to 20% of intracellular bacteria.33 34 
Proteome analysis of host cell membranes modified by Salmonella, indicated that ER membranes 
can be redirected to their intracellular niche.29 UPR activation can regulate ER membrane by 
increasing phospholipids and ER protein levels as well as modulating fatty acid, sphingolipid, 
phospholipid and sterol metabolism, which ultimately lead to expansion of ER membranes.25 26 26 35 
36 Our experiments with Triacin C, suggest that the long chain fatty acid CoA synthase (ACSL) 
family of proteins which are involved in fatty acid degradation, phospholipid remodelling and 
production of long chain acyl-CoA esters could well be involved in this pathway. 37 38  
 
Several intracellular bacteria such as Brucella and Legionella interact directly with ER membrane.39 
Recently it has been reported that Chlamydia, which is also associated with ReA40 can also induce 
ER stress responses for the purposes of exploiting host lipid metabolism.41 Interestingly both 
Chlamydia and Salmonella have been reported to associate with and/or recruit ER derived 
membranes.29 42 Bacterial species such as Salmonella that depend on expansion of membrane 
compartments to accomodate their growth would benefit from the enhanced lipid production that 
results from UPR activation. Together, along with observations that HLA-B27 can induce or alter the 
ER stress environment, UPR induction may be a common feature of intracellular bacteria that reside 
in vacuoles and may link with the pathology associated with ReA.    
  
 11 
 
FIGURE LEGENDS 
Figure 1; Salmonella exhibit enhanced replication in the prescence of HLA-B27 and can 
activate XBP-1 and ATF6. (A) 2D isoelectric focusing of lysates from B27.HC cells and 
immunoblotted with anti-V5 pK demonstrate dimer formation (arrow) (top panel) whilst B35.HC does 
not form dimers. (B) HLA.B27.HC expressing cells transfected with the XBP1DBD-venus reporter 
construct (UPR leads to a 26nt intronic sequence excision, leading to the expression of the venus 
fluorescent protein) and treated with increasing concentrations of thapsigargin (TPG) exhibit a 
reduced UPR threshold. (C) The fold increase in DBDXBP-1v activation following infection of HeLa 
cells with ST.mCherry at MOI 3:1, 50:1 and 100:1. (D) The fold increase in DBDXBP-1v activation 
following infection of HeLa cells with ST.mCherry. Non-infected cells (mCherry-) from the same well 
expressing DBDXBP-1v were used as non-infected controls to calculate the fold increase in XBP-1 
activation in the infected cells (mCherry+). No induction of XBP-1v activation was seen in cells 
treated with heat killed S. enterica Typhimurium (HTST), LPS and flagellin. (E) Activation of 
endogenous XBP-1s was demonstrated by qPCR. All cycle threshold (Ct) values were normalised 
to GAPDH and data plotted as a fold induction of XBP-1s mRNA compared to levels detected at 
baseline.  (F) The fold increase in ATF6 activation as measured by the cleaved cytosolic-FLAG 
tagged domain, following infection of HeLa cells with ST.mCherry. (G) Immunoblot with anti-FLAG 
tag antibody of ATF6 following infection in 2 separate experiments (INF 1 & 2) compared to non-
infected (NI) cells. Inactivated (i) and activated (a) ATF6  are denoted by arrows. (H) Relative fold 
increase of bacteria recovered from four individual experiments. Fold increases in Salmonella 
recovered were calculated based on cfu recovered from control E84. There in an average 4.2 fold 
increase in bacteria recovered from Salmonella infected HeLa.B27.HC cells relative to the E84 and 
HLA-B35.HC control lines 24hrs p.i. The Mann Whitney test was used to compare cfu recoveries 
between HLA-B35 and HLA-B27 expressing cell lines and exact p values calculated (*P=0.0286).  
 
Figure 2: Salmonella require an intact XBP-1 pahway for efficient replication (A) Graph 
comparing the MFI of infected cells. The MFI of both cells types were similar at early time points (1 
and 4hrs p.i.). When the bacteria enter log phase replication, the XBP-1-/- cells show much lower 
MFI values than XBP-1+/+ cells. Mean mCherry MFI values SEM are shown (n=3) and ANOVA was 
performed (p <0.0001) with Tukey’s multiple comparision post-test to determine if there were 
significant differences between individual groups P< 0.001(***). (B) The fold difference in the MFI of 
the XBP-1+/+/XBP-1-/- cells at the various time points p.i.(C) Recovery of viable bacteria from 
infected cells show similar differences between the XBP-1+/+ and XBP-1-/- cells at 8 and 24hrs p.i. 
Mean fold differences in cfu values (n=5 or 6) SEM are shown. The Mann Whitney test was used 
to compare cfu recoveries.  
 
Figure 3: Salmonella exhibit enhanced recovery from cells undergoing UPR. (A) 
Pharmacological UPR inducing agents and their mode of action. A23187 is a Ca2+ ionophore that 
disrupts intracellular Ca2+ levels. Thapsigargin is a non-competitive inhibitor of the SERCA pump 
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leading to  reduced Ca2+ ER concentrations. Tunicamycin inhibits the addition of carbohydrate 
(CHO) moities to newly synthesised proteins. MG132 inhibits proteasome mediated degradation 
leading to accumulation of misfolded proteins within the ER. Triacin C is also shown and inhibits de 
novo lipid synthesis. (B) Treatment of cells with UPR inducing drugs  increase the numbers of 
intracellular bacteria 24hrs p.i.. Cells were treated with A23187 (0.5mM), MG132 (0.5g/mL), TPG 
(200nM) and TUN (0.5g/mL). Mean fold increases in mCherry MFI values SEM are shown (n=3).  
ANOVA was performed on mCherry MFI values (p <0.0001) with Tukey’s multiple comparision post-
test to determine significant differences between individual groups P<0.05 (*) and P< 0.001 (***). (C-
D) TPG treated cells exhibit significant increases in MFI values of the infected cells when compared 
to DMSO controls (C) and in the fold difference in MFI values between the DMSO and TPG treated 
cells (D) in a concentration dependent manner. Mean MFI values SEM (n=3) are shown and 
ANOVA was performed (p <0.0001) with Tukey’s multiple comparision post-test used to determine if 
there were significant differences between DMSO and all drug treated groups at 24hrs p.i. P< 0.001 
(***). (E) Recovery of viable bacteria from infected cells exhibit similar fold differences between the 
DMSO and TPG treated cells infected at 24hrs p.i. Mean fold differences in cfu values (n= 6) SEM 
are shown. The Mann Whitney test was used to compare cfu recoveries between DMSO and TPG 
treated cells and exact p values calculated (*P=0.004 and **P=0.015).  
 
Figure 4: Salmonella require de novo lipid synthesis during enhanced recovery from cells 
undergoing UPR (A) HeLa cells were treated with DMSO, TRC (200nM) and TPG (200nM) or co-
treated with 200nM TRC and 200nM TPG at 16hrs prior to infection with ST.mCherry. TPG treated 
cells exhibit significant increases in the MFI values of the infected cells when compared to DMSO or 
TRC controls. Co-treatment of cells with TRC and TPG significantly reduces the effect of the TPG 
on levels of intracellular bacteria at 24hrs p.i. Mean mCherry MFI values SEM are shown (n=3) and 
ANOVA was performed (p<0.0001) with Tukey’s multiple comparision post-test to determine 
significant differences between individual drug treatment groups P<0.001 (***). (B) The fold 
difference in the MFI values of the DMSO, TRC, TPG and TRC/TPG treated cells. (C) Observation 
by FACS were confirmed by recovery of viable bacteria from similarly treated and infected cells. 
Colonies were counted and number of bacteria present per cell in each sample calculated (n=12). 
The Mann Whitney test was used to compare cfu recoveries between DMSO and TPG or TPG and 
TRC/TPG co-treated cells and exact p values calculated (***P=0.0001). 
 
Figure 5: Salmonella infection can increase endoreticular membranes and exhibit altered 
cellular location in the presence of HLA-B27 (A) Increases in numbers of intracellular bacteria in 
cells treated with UPR inducing drugs is dependent on intracellular replication of bacteria within the 
SCV. HeLa cells were treated with DMSO or 200nM TPG at 16hrs prior to infection with S. enterica 
Typhimurium 12023 or sifA strains expressing mCherry. Wild type bacteria which replicate within 
the SCV,  show increases in intracellular bacteria in the TPG treated samples while those infected 
with the sifA mutant show no increase in the TPG treated cells. (B) HeLa cells were infected with 
wild-type (WT) or sifA ST.mCherry, stained with ER tracker (green) at 4 and 24 hrs p.i. and 
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analyzed by confocal microscopy using a Opera LX plate reader. Quantification of endoreticular 
membrane content in infected cells. MFI of glibenclamide staining in infected (INF) and non-infected 
(NI) cells were compared at 4 and 24hrs p.i. after infection with either WT or sifA 12023. MFI 
values SEM are shown (n=135-1476). For B statistical analysis was performed using the Kruskal-
Wallis test (p <0.0001) and was performed with Dunn’s multiple comparision post-test to determine 
significant differences between individual groups P< 0.001(***).  
 
Figure 6: Salmonella exhibit altered cellular location in the presence of folding and 
misfolding HLA-B27 (A) Schematic of the MHC class I SCT used in this analysis. (B) HLA-
B27.SCT  (top left and right panel) can activate NP specific T cell clones and act as efficient targets 
in the absence of exogenous NP peptide (top left panel). HLA-B35.SCT does not activate NP-B27 
specific CTLs (bottom left and right). (C) 2D isoelectric focusing of lysates from B27.SCT and 
B35.SCT cells and immunoblotted with anti-V5 pK demonstrate no dimer formation. (D) Expression 
of HLA-B27 in the context of the SCT molecule reverses the enhanced bacterial recovery phenotype 
observed in HLA-B27 heavy chain expressing cells. ANOVA was performed (P=0.0033) with 
Tukey’s multiple comparison post test to determine significance between individual groups P<0.05 
(*, **). (E) Differences in bacteria recovered at later time points is not due to increased adhesion or 
invasion of HeLa.B27.HC by St.GFP. Flow cytometric analysis of cells infected with St.GFP over 
time shows no observed difference in the number of cells infected or relative number of bacteria per 
cell (as determined by MFI) until later infection time points i.e. >8 hrs p.i. Data is presented relative 
to results from control E84 cells. Two way ANOVA was performed (P<0.0001) with multiple t-tests to 
determine significance between individual groups P<0.0001  (****). (F) Salmonella (green) reside in 
SCVs associated with the Golgi apparatus, stained with Giantin (red) in HeLa.FLP (E84, control i) 
and HeLa.B35.HC (ii). HeLa.B27.SCT (iv) expressing cells exhibit no altered localisation of 
Salmonella when compared HLA-B27.HC (iii) Nuclei are stained with DAPI (blue).  
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